Tower Research Capital LLC (Trc) Nuvectis Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,849 shares of NVCT stock, worth $23,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,849Holding current value
$23,170% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding NVCT
# of Institutions
55Shares Held
3.84MCall Options Held
97.7KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA699KShares$4.21 Million0.0% of portfolio
-
Iridian Asset Management LLC586KShares$3.53 Million1.55% of portfolio
-
Ronit Capital LLP563KShares$3.39 Million5.37% of portfolio
-
Baldwin Brothers LLC390KShares$2.35 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA326KShares$1.96 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $88.1M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...